S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Beximco Pharmaceuticals Share Forecast, Price & News

GBX 67.50
-3.00 (-4.26%)
(As of 07/4/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
14,279 shs
Average Volume
26,995 shs
Market Capitalization
£301.13 million
P/E Ratio
Dividend Yield
Price Target

Beximco Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Short Interest
Dividend Strength
Based on Four Factors
News Sentiment
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.50 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Beximco Pharmaceuticals logo

About Beximco Pharmaceuticals (LON:BXP) Stock

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

BXP Stock News Headlines

Beximco Pharmaceuticals Ltd. GDR
Beximco Pharma Share Chat
Beximco Pharmaceut - Price Monitoring Extension
Beximco Pharma Share News (BXP)
Sanofi selects Beximco as potential buyer
Beximco Pharmaceuticals Limited (BXP.L)
Beximco Pharmaceuticals Limited (R2WA.SG)
State gives nod to Covid drug despite WHO's warning
See More Headlines

Industry, Sector and Symbol

Drug Manufacturers - Major
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales


Free Float
Market Cap
£301.13 million

Beximco Pharmaceuticals Frequently Asked Questions

How has Beximco Pharmaceuticals' stock price performed in 2022?

Beximco Pharmaceuticals' stock was trading at GBX 121.50 on January 1st, 2022. Since then, BXP stock has decreased by 44.4% and is now trading at GBX 67.50.
View the best growth stocks for 2022 here

Is Beximco Pharmaceuticals a good dividend stock?

Beximco Pharmaceuticals(LON:BXP) pays an annual dividend of GBX 3.47 per share and currently has a dividend yield of 4.16%. BXP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.

Who are Beximco Pharmaceuticals' key executives?

Beximco Pharmaceuticals' management team includes the following people:
  • Mr. Nazmul Hassan, MD & Director
  • Mr. Mohammad Ali Nawaz, Chief Financial Officer
  • Mr. S. M. Rabbur Reza, Chief Operating Officer
  • Mr. Jamal Ahmed Choudhury, Director of Accounts & Fin.
  • Mr. Rizvi Ul Kabir, Director of Marketing
  • Mr. M. A. Arshad Bhuiyan, Gen. Mang. of HR
  • Mr. Zakaria Seraj Chowdhury, Head of Distribution Services & Director of International Marketing
  • Mr. Mohammad Asad Ullah FCS, Company Sec. & Exec. Director
  • Mr. Prabir Ghose, Exec. Director of Quality Assurance

What is Beximco Pharmaceuticals' stock symbol?

Beximco Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "BXP."

How do I buy shares of Beximco Pharmaceuticals?

Shares of BXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Beximco Pharmaceuticals' stock price today?

One share of BXP stock can currently be purchased for approximately GBX 67.50.

How much money does Beximco Pharmaceuticals make?

Beximco Pharmaceuticals (LON:BXP) has a market capitalization of £301.13 million.

How many employees does Beximco Pharmaceuticals have?

Beximco Pharmaceuticals employs 5,500 workers across the globe.

How can I contact Beximco Pharmaceuticals?

Beximco Pharmaceuticals' mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The official website for Beximco Pharmaceuticals is www.beximco-pharma.com. The company can be reached via phone at +880-2-58611001.

This page (LON:BXP) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.